Profile picture

Doctor Derk Pol

Monash Heart, Melbourne (Australia)
Follow
Logo ESC

Contributor content

2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
Presentation
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
See more
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
Presentation
2-year real-world outcomes of prasugrel, ticagrelor or clopidogrel therapy following percutaneous coronary intervention from a large multi-centre Australian registry.
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources